Giovanni Bellomo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Plasma P-Tau217: A Powerful Alzheimer Disease Biomarker in the Right Clinical Context.

Plasma P-Tau217: A Powerful Alzheimer Disease Biomarker in the Right Clinical Context.

Journal: Neurology

Published: July 13, 2026

Toward harmonized reporting of Alzheimer's disease biomarkers in clinical practice.

Toward harmonized reporting of Alzheimer's disease biomarkers in clinical practice.

Journal: Clinical chemistry and laboratory medicine

Published: July 08, 2026

The contribution of Laboratory Medicine to Precision Neurology.

The contribution of Laboratory Medicine to Precision Neurology.

Journal: Clinical chemistry and laboratory medicine

Published: June 26, 2026

α-Synuclein Seed Amplification Assays: High Promise, Real-World Variability, and an Urgent Need for Standardization.

α-Synuclein Seed Amplification Assays: High Promise, Real-World Variability, and an Urgent Need for Standardization.

Journal: Neurology

Published: January 28, 2026

Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkers.

Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkers.

Journal: Cell & bioscience

Published: January 06, 2026

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.

Journal: Nature aging

Published: January 05, 2026

Blood-based biomarkers for Alzheimer's disease: influence of kidney function.

Blood-based biomarkers for Alzheimer's disease: influence of kidney function.

Journal: Alzheimer's research & therapy

Published: November 01, 2025

Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease.

Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease.

Journal: Neurobiology of disease

Published: September 15, 2025

Identifying Patients With Synucleinopathies: From Research Studies to Routine Clinical Practice.

Identifying Patients With Synucleinopathies: From Research Studies to Routine Clinical Practice.

Journal: Neurology

Published: September 08, 2025

Unlocking the full clinical potential of the α-synuclein seed amplification assay.

Unlocking the full clinical potential of the α-synuclein seed amplification assay.

Journal: The Lancet. Neurology

Published: May 28, 2025

Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease.

Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease.

Journal: Journal of Parkinson's disease

Published: May 23, 2025

Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy.

Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy.

Journal: Antioxidants (Basel, Switzerland)

Published: May 21, 2025

Showing 1-12 of 66

Last Updated: 09/26/2026